Published in Minerva Med on April 14, 1978
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke (1998) 1.57
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia. Clin Exp Immunol (2000) 0.95
The hyperfibrinolytic state of liver cirrhosis: possible pathogenetic role of ascites. Biomed Pharmacother (1993) 0.90
HLA typing in chronic type B, D and C hepatitis. J Hepatol (1996) 0.87
Effects "in vitro" of some cardiovascular drugs and other agents on human platelet aggregation. Thromb Diath Haemorrh (1973) 0.81
Bacillus subtilis selectively stimulates the synthesis of membrane bound and secreted IgA. Chemioterapia (1985) 0.81
Influence of an Aspergillus enzyme on ADP-induced platelet aggregation and fibrinolysis. Life Sci (1967) 0.81
Effect of intensive plasma exchange (PE) in rapidly progressive crescentic glomerulonephritis (RPCGN). Int J Artif Organs (1983) 0.80
Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. J Rheumatol (1995) 0.79
Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. QJM (1995) 0.79
Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis (1994) 0.78
Effect of manganese ions on human platelet aggregation in vitro. Experientia (1974) 0.77
Cross-reactive idiotypes on cryoprecipitating monoclonal IgMk rheumatoid factors. Clin Exp Rheumatol (1996) 0.77
AIDS-like immunologic alterations in clinically unaffected drug users. Am J Clin Pathol (1985) 0.77
Influence of brodimoprim on polymorphonuclear leukocyte phagocytosis and oxidant radical production. Chemotherapy (1996) 0.76
Modifications of bleeding time and intensity of prothrombin consumption and of fibrinolysis in rats after administration of platelet extracts alone and with antifibrinolytic agents. Farmaco Sci (1967) 0.75
[Effect of a blood extract on plasma lipids, blood coagulation, fibrinolysis and platelet aggregation in experimental hypercholesterolemia of rabbits]. Arzneimittelforschung (1974) 0.75
Clinical significance of endothelial damage markers in essential mixed cryoglobulinemia. Acta Haematol (1991) 0.75
T-lymphocyte subsets in primary and secondary glomerulonephritis. Proc Eur Dial Transplant Assoc (1983) 0.75
[Hyperfibrinolysis in maxillofacial surgery]. Rev Stomatol Chir Maxillofac (1976) 0.75
[Aggregation and adhesiveness of blood platelets in the physiopathology and prevention of thrombophilic states. Prospects and results of experimental and clinical research]. G Gerontol (1966) 0.75
[Hemorrhagic myocardial infarct in a newborn infant with the consumption coagulopathy syndrome]. Minerva Pediatr (1971) 0.75
Increased monocyte procoagulant activity (tissue factor) in patients with essential mixed cryoglobulinemia. Am J Clin Pathol (1986) 0.75
[Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate]. Clin Ter (1966) 0.75
The action of a thrombolytic agent, protease I (Aspergillus enzyme, Brinase) on fibrinogen turnover. Farmaco Sci (1973) 0.75
[Research on prolonged prophylactic treatment of thrombophilic states by an activation of hematic fibrinolysis]. G Gerontol (1965) 0.75
[IgA-IgG-IgM serum levels in blood donors. Examination of some variables]. Boll Ist Sieroter Milan (1976) 0.75
[Antithrombotic and antidyslipemic action of di-isopropylammonium dichlorethanoate in animals and man]. Farmaco Prat (1971) 0.75
Beta-blocking drugs and human platelet aggregation in vitro. Experientia (1973) 0.75
[Cardiovascular effects of S 2620 in dogs anesthetized with pentobarbital]. C R Seances Soc Biol Fil (1977) 0.75
[Clinical and experimental research on prolonged fibrinolytic treatment. 2. Activation of fibrinolysis by prolonged administration of nicotinic acid derivatives]. Hemostase (1965) 0.75
Acquired factor VIII inhibitor in a non-haemophilic patient: successful treatment with plasma exchange associated with factor VIII concentrate and immunosuppressors. Haemostasis (1984) 0.75
[Contribution to the study of HBSAg in blood donors. III. Testing of various biochemical parameters in HBSAg positive subjects]. Riv Emoter Immunoematol (1977) 0.75
[Studies on the fibrinolytic action of heparin substance in man]. Arzneimittelforschung (1965) 0.75
[Respiratory stimulant effect of S 2620 in the dog anesthetized with pentobarbital]. C R Seances Soc Biol Fil (1975) 0.75
[Behavior of clotting factors in the blood and plasma preserved in A.C.D. and C.P.D]. Boll Ist Sieroter Milan (1974) 0.75
[Thromboelastographic changes in patients treated with an anovulatory drug with estro-progestinic action]. Minerva Ginecol (1969) 0.75
Ticlopidine administration to patients does not inhibit the ability of their monocytes to form rosettes and to phagocytize erythrocytes in vitro. Int J Tissue React (1987) 0.75
[Clinical experience in the hemorrhagic disease (1964-1969)]. Minerva Med (1971) 0.75
A pyridoxylated polymerized hemoglobin solution as oxygen carrying substitute. Int J Artif Organs (1983) 0.75
Synergistic effect of SH-containing compounds and prednisolone in increasing platelets in rats. Hemostase (1966) 0.75
[Estroprogestinic associations in the preclimacteric syndrome: blood coagulation problems]. G Gerontol (1969) 0.75
Clinical significance of cross-linked fibrin degradation products in essential mixed cryoglobulinemia. Biomed Pharmacother (1988) 0.75
A study on lipidic metabolism by means of radioactive triolein and on fibrinolysis in aged subjects treated for six months with a duodenal sulfated polysaccharide. Arzneimittelforschung (1969) 0.75
Preliminary report on the use of brinase from Asperguillus oryzae in cases of arterial venous shunt occlusions. Farmaco Prat (1972) 0.75
[Quantitative study of factor VIII in blood donors]. Minerva Med (1969) 0.75
Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes. Chemotherapy (1997) 0.75
[Not Available]. Mov Operaio Soc (1982) 0.75
[Stimulating action on respiration of S2620 in the rabbit anesthetized with pentobarbital]. C R Seances Soc Biol Fil (1974) 0.75
[Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin]. Clin Ter (1974) 0.75
Lymphocyte populations in the peripheral blood from patients with IgA nephropathy. Nephron (1982) 0.75
[Detection of HBsAg in blood donors. II. Statistical analysis of a sample of regular and occasional donors]. Riv Emoter Immunoematol (1977) 0.75
Action of the proteinase inhibitor (trasylol) on the fibrinogen turnover. Farmaco Sci (1970) 0.75
Anti-mesangial and anti-endothelial cell antibodies in IgA mesangial nephropathy. Clin Nephrol (1995) 0.75
Structural and functional characterization of plasma fibronectin in patients with essential mixed cryoglobulinaemia. Eur J Clin Chem Clin Biochem (1992) 0.75
[A new immunoenzyme method for detecting hepatitis B surface antigen : comparison with radioimmunoassay and reversed hemagglutination]. Riv Emoter Immunoematol (1978) 0.75
Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate. Farmaco Sci (1973) 0.75
[Not Available]. Mov Operaio Soc (1980) 0.75
[Rehabilitation in myocardial infarct. Study of various coagulation parameters and platelet function]. Minerva Med (1983) 0.75
[Experimental and clinical studies on a protease from Aspergillus oryzae (Brinase): fibrinogen turnover, thrombocyte aggregation and occlusion of the Scribner shunt]. Folia Haematol Int Mag Klin Morphol Blutforsch (1974) 0.75
Fibrinolytic activity and reduction of platelet adhesiveness following prolonged administration of ethyl-chlorophenoxy-isobutyrate (Atromid-S). Hemostase (1966) 0.75
-Pyridylcarbinol in experimental hypercholesterinemia of the rabbit. Study of lipidic fractions and of the mechanisms of hemostasis. Farmaco Sci (1972) 0.75
Significance of hepatitis C virus genotypes and viral load in patients with "essential" mixed cryoglobulinemia. Clin Exp Rheumatol (1996) 0.75
Action of epsilon-aminocaproic acid and of parotid inhibitor on the fibrinolysis activation due to nicotinic acid derivatives and to heparin-like substances. Farmaco Sci (1966) 0.75
"In vitro" production of immunoglobulins and rheumatoid factor by peripheral lymphocytes of aged humans. Quad Sclavo Diagn (1986) 0.75
Immunological monitoring of a patient with Guillain-Barré syndrome successfully treated with plasma exchange. Vox Sang (1982) 0.75
[Changes in bleeding time in rats induced with local application of adenosine and its derivatives and other substances]. Minerva Med (1969) 0.75
Effect of 4-aminomethylcyclohexanecarboxylic acid on fibrinogen turnover. Farmaco Prat (1972) 0.75
[Changes in the in vitro antibody formation in B lymphoproliferative diseases]. Minerva Med (1985) 0.75
Plasma exchange in glomerulonephritis associated with systemic lupus erythematosus and essential mixed cryoglobulinemia. Int J Artif Organs (1983) 0.75
[Cardiorespiratory response to submaximal effort in old subjects]. G Gerontol (1970) 0.75
Prevalence of some markers of the hepatitis B virus in a blood donor population. Boll Ist Sieroter Milan (1982) 0.75
Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions. New Istanbul Contrib Clin Sci (1972) 0.75
[Hemorrhagic infarct of the myocardium in a newborn with consumption coagulopathic syndrome]. Minerva Pediatr (1971) 0.75
Correlations between hemostasis and lipidic patterns in hypercholesterinemic rabbits and arteriosclerotic patients under the treatment with di-isopropylammonium dichloroetanoate. Acta Univ Carol Med Monogr (1972) 0.75
[Various parameters of hemostasis in patients with chronic liver diseases]. Minerva Med (1985) 0.75
Fibrinogen turnover during the treatment with xantinol nicotinate. Arzneimittelforschung (1971) 0.75
[Standardization of methods for the preparation of blood components: examination of the operational characteristics of various centrifuges]. Rev Fr Transfus Immunohematol (1986) 0.75
[Effect of 2-methyl-2-(4-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy)propionic acid (Su-13437) on lipid fractions, fibrinolysis and platelet aggregation in rabbits with experimental hypercholesterolemia]. Farmaco Prat (1974) 0.75
Comparative study of coagulation, fibrinolysis and cardiorespiratory function in elderly and young subjects after exercise. J Am Geriatr Soc (1972) 0.75
The activity of a beta subtype of protein kinase C purified from nuclei of human neutrophils is enhanced by treatment with phorbol 12-myristate 13-acetate. Biochem Biophys Res Commun (1991) 0.75
Comparative research on the fibrinolytic action of different nicotinic acid derivatives following their prolonged administration into rabbits. Thromb Diath Haemorrh (1966) 0.75
Correlation between helper/suppressor ratio and IgA levels in the peripheral blood from patients with liver diseases. Biomed Pharmacother (1983) 0.75